Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Der nächste Perpetua? Warum NevGolds neueste Bohrergebnisse den Vergleich mit dem Milliardenwert PPTA nähren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14W4W | ISIN: SE0007577895 | Ticker-Symbol: 6Y4
Tradegate
04.06.25 | 16:02
0,856 Euro
+0,12 % +0,001
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
VICORE PHARMA HOLDING AB Chart 1 Jahr
5-Tage-Chart
VICORE PHARMA HOLDING AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,8460,86412:37
0,8470,86206.06.

Aktuelle News zur VICORE PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.05.Vicore Pharma Holding: Vicore to Present at the Jefferies Global Healthcare Conference192STOCKHOLM, SE / ACCESS Newswire / May 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced...
► Artikel lesen
22.05.Vicore Pharma Holding: Vicore Presents New Data at the 2025 American Thoracic Society International Conference276STOCKHOLM, SE / ACCESS Newswire / May 22, 2025 / Vicore Pharma Holding (STO:VICO) - Stockholm, May 22, 2025 - Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs,...
► Artikel lesen
06.05.Bulletin from the Annual General Meeting of Vicore Pharma Holding AB269STOCKHOLM, SE / ACCESS Newswire / May 6, 2025 / Vicore Pharma Holding (STO:VICO) - The following resolutions were passed at the annual general meeting (the "AGM") of Vicore Pharma Holding AB (publ)...
► Artikel lesen
06.05.Vicore Pharma Holding: Interim Report January - March 2025341STOCKHOLM, SE / ACCESS Newswire / May 6, 2025 / Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs)...
► Artikel lesen
02.05.Vicore Pharma Holding: Vicore to Present at the Nordea Equities Healthcare Seminar511STOCKHOLM, SE / ACCESS Newswire / May 2, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced...
► Artikel lesen
23.04.Vicore Pharma Holding: Vicore Announces Presentations at the 2025 American Thoracic Society International Conference302STOCKHOLM, SE / ACCESS Newswire / April 23, 2025 / Vicore Pharma Holding (STO:VICO)Stockholm, April 23, 2025 - Vicore Pharma Holding AB (STO: VICO), unlocking the potential of a novel class of drugs...
► Artikel lesen
VICORE PHARMA Aktie jetzt für 0€ handeln
28.03.Vicore Pharma Holding: Vicore to Participate in the Van Lanschot Kempen Life Sciences Conference776STOCKHOLM, SE / ACCESS Newswire / March 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced...
► Artikel lesen
26.03.Notice of Annual General Meeting of Vicore Pharma Holding AB278STOCKHOLM, SE / ACCESS Newswire / March 26, 2025 / Vicore Pharma Holding (STO:VICO)The shareholders of Vicore Pharma Holding AB (publ), Reg. No. 556680-3804 ("Vicore Pharma" or the "company"), with...
► Artikel lesen
26.03.Vicore Pharma Holding: Vicore Publishes the Annual Report for 2024270STOCKHOLM, SE / ACCESS Newswire / March 26, 2025 / Vicore Pharma Holding (STO:VICO) Stockholm, March 26, 2025 - Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs...
► Artikel lesen
27.02.Vicore Pharma Holding Year-End Report 2024324STOCKHOLM, SWEDEN / ACCESS Newswire / February 27, 2025 / Vicore Pharma Holding (STO:VICO) Stockholm, February 27, 2025 - Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a...
► Artikel lesen
26.02.Vicore Pharma Holding: Vicore to Present at Upcoming Investor Conferences269STOCKHOLM, SWEDEN / ACCESS Newswire / February 26, 2025 / Vicore Pharma Holding (STO:VICO) Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type...
► Artikel lesen
19.09.24Nasdaq Stockholm AB: Listing of subscription rights and Paid subscription shares of Vicore Pharma Holding AB630With effect from September 20, 2024, the subscription rights of Vicore Pharma Holding AB will be traded on the list for Equity rights. Trading will continue up until and including October 01, 2024....
► Artikel lesen
16.09.24XFRA CAPITAL ADJUSTMENT INFORMATION - 16.09.2024488Das Instrument WD9 CA5368771039 LI3 LITHIUM CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 16.09.2024 und ex Kapitalmassnahme am 17.09.2024 The instrument WD9 CA5368771039 LI3 LITHIUM CORP. EQUITY...
► Artikel lesen
10.09.24Vicore Pharma Holding AB: Vicore Pharma announces a rights issue of approximately SEK 782 million210THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF...
► Artikel lesen
22.08.24Vicore Pharma Holding AB: Interim report April-June 2024475Stockholm, August 22, 2024- Vicore Pharma Holding AB (STO: VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1